Katharina Schutz
Carl Neuberg Str. 1
Hannover, NI 30625, Germany
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Long-term impact of elexacaftor/tezacaftor/ivacaftor on small and large airways in people with cystic fibrosis aged ≥6 years: 24-month real-world evidence from the German Cystic Fibrosis Registry.
Journal: ERJ open research
Published: June 13, 2025
Rigid and Flexible Bronchoscopy for Foreign Body Removal in Children: Complications, Risk Factors and Anesthetic Management.
Journal: Pediatric pulmonology
Published: March 11, 2025
Cystic fibrosis transmembrane conductance regulator therapy with elexacaftor/tezacaftor/ivacaftor reduces detection of hallmark cystic fibrosis pathogens in Europe: progress made but no time to slow down.
Journal: ERJ open research
Published: February 13, 2025
Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosis.
Journal: The European respiratory journal
Published: January 23, 2025
CFTR Modulator Treatment in Children<12 Years of Age - Status Quo and Challenges.
Journal: Klinische Padiatrie
Published: December 10, 2024
Pediatric lung transplantation for childhood interstitial lung disease: Indications and outcome.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: November 26, 2024
JAK inhibitors to treat STAT3 gain-of-function: a single-center report and literature review.
Journal: Frontiers in immunology
Published: March 13, 2024
Ten-year experience of whole lung lavage in pediatric Pulmonary Alveolar Proteinosis.
Journal: Klinische Padiatrie
Published: January 23, 2024
Relapsing Polychondritis with Tracheobronchial Involvement: A Detailed Description of Two Pediatric Cases and Review of the Literature.
Journal: Klinische Padiatrie
Published: January 15, 2024
Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.
Journal: The European respiratory journal
Published: January 01, 2024
Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis.
Journal: ERJ open research
Published: May 31, 2023
Variants in FGF10 cause early onset of severe childhood interstitial lung disease: A detailed description of four affected children.
Journal: Pediatric pulmonology
Published: May 22, 2023
Last Updated: 09/26/2026